These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 7665549)
1. Seroquel: a putative atypical antipsychotic drug with serotonin- and dopamine-receptor antagonist properties. Preclinical and early clinical trials in schizophrenia. J Clin Psychiatry; 1995 Sep; 56(9):438-45. PubMed ID: 7665549 [No Abstract] [Full Text] [Related]
2. The scourge of EPS: have atypical antipsychotics solved the problem? J Clin Psychiatry; 2000 Dec; 61(12):955-62. PubMed ID: 11206607 [No Abstract] [Full Text] [Related]
3. In vivo serotonin 5-HT(2A) receptor occupancy and quetiapine. Jones HM; Travis MJ; Mulligan R; Visvikis D; Gacinovic S; Ell PJ; Kerwin RW; Pilowsky LS Am J Psychiatry; 2000 Jan; 157(1):148. PubMed ID: 10618043 [No Abstract] [Full Text] [Related]
4. Seroquel (ICI 204 636), a putative "atypical" antipsychotic, in schizophrenia with positive symptomatology: results of an open clinical trial and changes of neuroendocrinological and EEG parameters. Wetzel H; Szegedi A; Hain C; Wiesner J; Schlegel S; Benkert O Psychopharmacology (Berl); 1995 May; 119(2):231-8. PubMed ID: 7659771 [TBL] [Abstract][Full Text] [Related]
6. Effects of 'Seroquel' (quetiapine) on platelet serotonin-2 binding in schizophrenia. Faustman WO; Ringo DL; Lauriello J; Lim KO; Pfefferbaum A J Clin Psychopharmacol; 1996 Dec; 16(6):464-6. PubMed ID: 8959478 [No Abstract] [Full Text] [Related]
7. D2 and 5-HT2 receptor effects of antipsychotics: bridging basic and clinical findings using PET. Remington G; Kapur S J Clin Psychiatry; 1999; 60 Suppl 10():15-9. PubMed ID: 10340683 [TBL] [Abstract][Full Text] [Related]
8. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine. Tada M; Shirakawa K; Matsuoka N; Mutoh S Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255 [TBL] [Abstract][Full Text] [Related]
9. Review of quetiapine and its clinical applications in schizophrenia. Kasper S; Müller-Spahn F Expert Opin Pharmacother; 2000 May; 1(4):783-801. PubMed ID: 11249516 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the effects of receptor-selective ligands in rats discriminating the novel antipsychotic quetiapine. Goudie AJ; Smith JA; Millan MJ Psychopharmacology (Berl); 2004 Jan; 171(2):212-22. PubMed ID: 14691616 [TBL] [Abstract][Full Text] [Related]
11. Creating more effective antidepressants: clues from the clinic. Rasmussen K Drug Discov Today; 2006 Jul; 11(13-14):623-31. PubMed ID: 16793531 [TBL] [Abstract][Full Text] [Related]
12. [The use of Seroquel in schizophrenia]. Chakhava VO Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(9):63-4. PubMed ID: 11026140 [No Abstract] [Full Text] [Related]
13. Clarification of anticholinergic effects of quetiapine. Goldstein JM; Brecher M J Clin Psychiatry; 2000 Sep; 61(9):680. PubMed ID: 11030492 [No Abstract] [Full Text] [Related]
15. Quetiapine: a review of its use in acute mania and depression associated with bipolar disorder. Dando TM; Keating GM Drugs; 2005; 65(17):2533-51. PubMed ID: 16296876 [TBL] [Abstract][Full Text] [Related]
18. Quetiapine fumarate for schizophrenia and bipolar disorder in young patients. Ribolsi M; Magni V; Rubino IA Drugs Today (Barc); 2010 Aug; 46(8):581-7. PubMed ID: 20830318 [TBL] [Abstract][Full Text] [Related]
19. Focus on quetiapine. Green B Curr Med Res Opin; 1999; 15(3):145-51. PubMed ID: 10621920 [TBL] [Abstract][Full Text] [Related]